DRG International, Inc.

841 Mountain Avenue
Springfield,  NJ  07081

United States
http://www.drg-international.com
  • Booth: 3713

DRG International, Inc., founded in 1970 in the USA, is a global innovator of high-quality medical diagnostics and equipment, providing the medical and research community with cutting edge, effective tools to build a healthier future. NEW ELISAS: Hepcidin-25 bioactive HS (EIA5782) Salivary Hormone ELISAS Aldosterone (EIA5298) Active Renin (EIA5125) 25-OH Vitamin D (EIA5396) NEW DRG:Hybrid•XL FULLY AUTOMATED IMMUNOASSAY & CLINICAL CHEMISTRY ANALYZER Please visit www.drg-international.com for details!


 Press Releases

  •  

    FOR IMMEDIATE RELEASE

     

    Contact:                 Gregory Guest

                                    (973) 564-7555

                                    marketing@drg-international.com

     

     

    DRG® 25-OH Vitamin D (total) ELISA at 2016 AACC Conference (Booth 3713)

    - Leading ELISA Manufacturer to showcase Vitamin D research kit -

    Springfield, New Jersey, USA (July 2016)— The DRG® 25-OH Vitamin D (total) ELISA, an enzyme immunoassay for the measurement of total 25-OH Vitamin D (Vitamin D2 and Vitamin D3) in both serum and plasma, will be a highlight of the 2016 American Association for Clinical Chemistry (AACC) Conference on August 02-04 in Philadelphia, Pennsylvania.

    Vitamin D is involved in the intestinal absorption of calcium and the regulation of calcium homeostasis. Deficiency of Vitamin D can result in a wide-range of health issues in people of any age.  Most commonly, a deficiency is related to issues in bone development but Vitamin D deficiency can also affect general health and cause many other problems including: types of cancer, hypertension, diabetes, and various autoimmune conditions.

    “Vitamin D testing is an increasingly important spectrum in the diagnostic field,” said Dr. Cyril E. Geacintov, founder, president and CEO of DRG International. “With more and more implications for the effects of Vitamin D deficiency being investigated all the time, this testing kit is increasingly sought by the research community.”

    Presently, this innovative technology is for research use only in the United States and is not for use in diagnostic or therapeutic procedures. However, it has received its CE Mark and is currently pending FDA approval. The DRG Instruments GmbH manufacturing and subsidiary company (Marburg, Germany) has also recently been awarded the Certificate of Proficiency by the Vitamin D External Quality Assessment (DEQUAS) Panel and meets the performance target set by DEQUAS for 25 hydroxyvitamin D.

    DRG International will be showcasing at the AACC in Booth 3713.  Press inquiries are welcome. For more information or appointment request, please contact Gregory Guest (International Marketing Manager for DRG International) at (973) 564-7555.

    ~*~

    DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

    DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com

  •  

    FOR IMMEDIATE RELEASE

     

    Contact:               Michael Martini

                                    (973) 564-7555

                                    marketing@drg-international.com

     

    DRG® International, Inc. to Showcase at 2016 AACC (Booth 3713)

     

    The Newly Optimized Saliva ELISA Assays

     

    Springfield, New Jersey, USA (July 2016)- DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG® Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04. DRG® Optimized Saliva ELISA Assays are easy-to-use, non-invasive sampling test kits designed for the measurement of the free (unbound) fraction of steroids. These tests allow for simple, patient-friendly measurement of hormone profiles. They are also a reliable measurement of steroids in veterinary saliva samples without further pre-treatment.

     

    DRG® Optimized Saliva ELISAS include:

    • DHEA
    • Cortisol
    • Estradiol
    • Testosterone
    • Progesterone

     

    Clear Advantages:

    • FDA CLEARED  TESTS
    • Increased stability and linearity
    • Ready to use reagents and user friendly assays
    • Non-invasive, easy sampling particularly for babies and children
    • Higher diagnostic relevance with reproducible and reliable results compared to serum analytics
    • EXCELLENT CORRELATION TO MASS SPECTROMETRY

     

    DRG® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic equipment. DRG® International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products.

     

    DRG International will be showcasing at the AACC in Booth 3713.  Press inquiries are welcome. For more information, please contact Michael Martini (Sales & Marketing Director for DRG International) at (973) 564-7555.

     

    ~*~

    DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

    DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com

  •  

    FOR IMMEDIATE RELEASE

     

    Contact:                 Gregory Guest

                                    (973) 564-7555

                                    marketing@drg-international.com

     

     

    DRG® Renin (active) ELISA to be showcased at 2016 AACC (Booth 3713)

    - This industry-leading ELISA testing kit for hypertension detection to be presented by DRG team -

    Springfield, New Jersey, USA (July 2016)- DRG International’s Renin (Active) ELISA for testing of active Renin in human EDTA plasma will be on display at the AACC’s 2016 show in Philadelphia, Pennsylvania on August 02-04. The DRG® Renin active ELISA test is accurate in testing for certain types of hypertension and has been utilized by labs world-wide.

    By measuring the active renin levels in a sample, the DRG® Renin (Active) ELISA (EIA-5125) can also effectively detect hypertension in a pregnancy. This early discovery opens up a much more effective array of treatment methods for the patient.

    “The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for Renin,” said Dr. Cyril E. Geacintov, founder, president and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”

    The DRG Renin (Active) ELISA is a solid phase enzyme-linked immunosorbent assay based on the sandwich principle.

    DRG International will be showcasing at the AACC in Booth 3713.  Press inquiries are welcome. For more information, please contact Gregory Guest (International Marketing Manager for DRG International) at (973) 564-7555.

     

    ~*~

     

    DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

    DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com

  •  

    FOR IMMEDIATE RELEASE

     

    Contact:               Michael Martini

                                    (973) 564-7555

                                    marketing@drg-international.com

     

    DRG® Hepcidin 25 (bioactive) HS Elisa to Showcase at 2016 AACC (Booth 3713)

    -This revolutionary testing kit will be on display, with DRG scientific team on hand for in-depth discussion-

     

    Springfield, New Jersey, USA (July 2016)- DRG International, a leading international medical diagnostic company, will showcase the NEW DRG® Hepcidin 25 (bioactive) HS (High Sensitive) ELISA Kit (EIA-5782) at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04.  As the first of its kind to market, this kit accurately detects bioactive Hepcidin levels as an additional marker to aid in identifying a variety of disorders.  In recent years, a large number of publications identify Hepcidin as a factor in regulating the amount of iron in humans.  Unbalanced iron level can lead to many common medical conditions including anemia and iron overload disease, and can occur in chronic kidney disease, inflammation, or diabetes mellitus.

     

    “We at DRG International saw the need for an accurate and easy to use Hepcidin testing kit and are encouraged by the great success that our research customers have seen using the product,” stated Dr. Cyril E. Geacintov, founder, president and CEO of DRG International. “This kit is an important step to meet the rapidly growing worldwide interest in Hepcidin testing and the applications of that testing in the health and wellness community.”

    The DRG® Hepcidin 25 (bioactive) HS ELISA Kit is available worldwide, providing a simple, fast and accurate method to test Hepcidin levels. DRG currently holds 17 US and International active patents on this product. The measurement results of this kit offer more information to help treat medical issues including iron deficiency diseases, which are some of the most common diseases worldwide. The kit is for Research Use Only (RUO) in the United States and is also CE marked.

     

    DRG International will be showcasing at the AACC in Booth 3713.  Press inquiries are welcome. For more information, please contact Michael Martini (Sales & Marketing Director for DRG International) at (973) 564-7555.

     

    ~*~

    DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

    DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com

  • FOR IMMEDIATE RELEASE

     

    Contact:                 Gregory Guest

                                    (973) 564-7555

                                    marketing@drg-international.com

     

     

    DRG® Aldosterone ELISA Kit at the AACC 2016 (Booth 3713)

    - Diagnostic and Research product manufacturer to showcase ELISA kit which differentiates between primary and secondary Aldosteronism -

    Springfield, New Jersey, USA (July 2016)— DRG International, a leading international medical diagnostic company, will showcase its DRG® Aldosterone ELISA Kit at the 2016 AACC in Philadelphia, Pennsylvania on August 02-04.  The DRG International Aldosterone ELISA is for measurement of Aldosterone in serum, plasma, and urine.

    Aldosterone regulates levels of sodium and potassium in the body and also controls blood pressure as well as fluids and electrolytes in the blood.  Measurement of aldosterone levels in serum in conjunction with plasma renin levels (aldosterone/renin-ratio; ARR) can be used to differentiate between primary and secondary aldosteronism. The differentiation is vital in the treatment and management of the disease.

    “The importance of testing Aldosterone is growing in the research and clinical communities,” said Dr. Cyril E. Geacintov, founder, president and CEO of DRG International.  “The accuracy and ease of use of this kit make it a top choice of researchers world-wide.”

    The DRG® Aldosterone ELISA Kit is an exciting addition to the laboratory field. It is a solid phase enzyme-linked immunosorbent assay (ELISA) based on the competitive principle. The Aldosterone ELISA Kit is available globally, and for research use only in the United States.

    DRG International will be showcasing at the AACC in Booth 3713.  Press inquiries are welcome. For more information, please contact Gregory Guest (International Marketing Manager for DRG International) at (973) 564-7555.

     

    ~*~

    DRG International, Inc. founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor with successful operations in over 110 countries.

    DRG supplies an extensive line of immunodiagnostic products including fertility and pregnancy tests, endocrinology/diabetes, saliva hormone diagnostics, tumor markers, infectious diseases, immunology/hematology, thyroid function panels, cardiovascular assays as well as therapeutic and toxicology screening products. To obtain more information about the DRG group of companies and complete product line, please visit our New website at:  www.drg-international.com


 Additional Info

Included in Export Interest Directory?
Yes
Business Needs:
Licensing Agreements
Products to be exported:
Medical Diagnostics (ELISA Test Kits and Research Products),
 Medical Instruments (Chemical Analyzers and ELISA Plate Readers)

 

  •  
    • AACC Annual Scientific Meeting & Clinical Lab Expo Management
    • SPARGO, Inc.
    • Toll Free (800) 564-4220
    • Phone:  (703) 631-6200
    • Fax (703) 563-2691
    • Email:  aaccexhibits@spargoinc.com
  •